Gedeon Richter PLC Gedeon Richter PLC

Gedeon Richter PLC

GEDSF

Peringkat dalam Saham #3656
Gedeon Richter Plc is a company focused on the development and manufacturing of... Gedeon Richter Plc is a company focused on the development and manufacturing of pharmaceutical products. Its operations are organized into three primary divisions: Pharmaceuticals, Wholesale & Retail, and Other. The Pharmaceutical segment covers all aspects from the research and development of new drugs and their production, through to their sales and marketing. The Wholesale & Retail division is responsible for distributing the company's products to consumers via its network of affiliated companies and pharmacies across various regional markets. The Other segment includes services provided by group members that support marketing and sales activities. The company was established in 1901 by Gedeon Richter and is headquartered in Budapest, Hungary.
Harga Saham
$24.85
Terakhir disinkronkan: 2026-10-20
Kapitalisasi Pasar
$4.54B
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
HU
Perdagangan Gedeon Richter PLC (GEDSF)

Kategori

Healthcare
Laba untuk Gedeon Richter PLC (GEDSF)
Laba pada 2026 TTM: 0
Menurut laporan keuangan terbaru dari Gedeon Richter PLC, laba saat ini perusahaan adalah 0. Pada tahun 2026, perusahaan memperoleh laba sebesar 0, sama dengan laba tahun 2026 sebesar 0. Laba yang ditampilkan di halaman ini adalah laba sebelum bunga dan pajak, atau disebut juga EBIT.
Riwayat laba untuk Gedeon Richter PLC dari 2004 hingga 2026
Laba pada akhir setiap tahun
Tahun Laba Mengubah
2025 $806.78M 13.46%
2024 $711.08M 43.95%
2023 $493.98M 11.34%
2022 $443.68M 0.42%
2021 $441.82M 14.81%
2020 $384.83M 126.37%
2019 $170.00M 8.29%
2018 $156.98M 192.08%
2017 $53.75M -76.26%
2016 $226.35M 9.52%
2015 $206.67M 109.14%
2014 $98.82M -51.07%
2013 $201.97M -9.84%
2012 $224.03M 1.12%
2011 $221.55M -32.00%
2010 $325.80M 7.89%
2009 $301.97M 35.80%
2008 $222.36M 9.50%
2007 $203.07M -24.96%
2006 $270.63M 25.32%
2005 $215.95M -2.41%
2004 $221.28M 0.00%
Laba untuk perusahaan serupa atau pesaing